COMPLEX CONTAINING MEQUITAZINE, CYCLODEXTRIN AND REACTION AGENT Russian patent published in 2010 - IPC A61K31/5415 A61K31/70 A61P37/08 A61P11/06 

Abstract RU 2389491 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutics and concerns a complex containing mequitazine, cyclodextrin and a reaction agent where the molar ration within the system mequitazine/cyclodextrin/the reaction agent and mequitazine/the reaction agent is 1/1 - 1/10 and water-dissolution rate of mequitazine being a part of the complex measured for an aqueous solution with mequitazine concentration 2 g/l at 35°C after 15 minutes of stirring, makes more than 50% at pH 9, to a method for preparing said complex and a based pharmaceutical composition.

EFFECT: invention provides improved solubility of mequitazine.

20 cl, 1 dwg, 1 tbl, 3 ex

Similar patents RU2389491C2

Title Year Author Number
INCLUSION COMPLEXES OBTAINED USING CO IN SUPERCRITICAL STATE AND AGENT FOR REACTION WITH COMPLEX 2005
  • Fress Bernar
  • Mars'Jak Florans
  • Loshar Juber
RU2382654C2
SOLID PHARMACEUTICAL PREPARATIONS CONTAINING PHYSICAL MIXTURE OF CYCLODEXTRIN SULFOALKYL ETHER AND THERAPEUTIC AGENT 1998
  • Stella Valentino K.
  • Makdzhiniti Dzhejms V.
  • Radzhevski Rodzher A.
RU2173172C2
AQUEOUS COMPOSITION CONTAINING DANTROLENE 2016
  • Shvebel, Erve Zhan
  • Adamo, Vinsent
RU2729043C2
ESTRAMUSTINE COMPOSITIONS WITH IMPROVED PHARMACEUTICAL PROPERTIES 1995
  • Martini Alessandro
  • Makkari Dzhuzeppe
  • Mudzhetti Lorena
  • Kolombo Dzhuzeppe
  • Butstsi Dzhovanni
RU2179036C2
COMPLEX INCLUDING N-ETHOXYCARBONYL-3- MORPHOLINESYDNONEIMINE OR SALT THEREOF WITH CYCLODEXRIN OR CYLODEXTRIN DERIVATIVE, METHOD OF PREPARING SAID INCLUSION CONTEX, PHARMACEUTICAL COMPOSITIONS AND METHOD OF PREPARATION THEREOF, AND TREATMENT METHOD 1991
  • Marija Vikmon[Hu]
  • Jozhef Sejtli[Hu]
  • Jozhef Gaal[Hu]
  • Ishtvan Khermets[Hu]
  • Agnesh Khorvat[Hu]
  • Katalin Marmaroshi[Hu]
  • Gabor Khorvat[Hu]
  • Irejn Munkachi[Hu]
RU2111216C1
VELDORETID, HAVING POOR SOLUBILITY IN PHYSIOLOGICAL CONDITIONS, FOR USE IN TREATING ACROMEGALY, ACROMEGALY WITH MALIGNANT GROWTH, EXPRESSING SST-R5 TUMORS, TYPE 2 DIABETES, HYPERGLYCEMIA AND TUMORS ASSOCIATED WITH HORMONES 2017
  • Afargan, Majkl
RU2736590C2
METHOD OF OBTAINING MOLECULAR COMPLEXES 2004
  • Loshar Juber
  • Soso Mars'Jal'
  • Fress Bernar
RU2353392C2
HIGH-BIOACCESS OROMUCOSAL PHARMACEUTICALS BASED ON CYCLODEXTRIN AND SUCRALOSE 2017
  • Bellorini, Lorentso
  • Nochelli, Luka
  • Fossati, Titsiano
RU2736245C2
INCLUSION COMPLEXES OF BUTYLPHTHALIDE WITH CYCLODEXTRIN OR ITS DERIVATIVES, METHOD FOR THEIR PREPARING AND THEIR USING 2002
  • Nju Chzhan'-Tsi
  • Chzhao Kaj
  • Lju Vehn'-Tszjuan'
  • Chzhou Guj-Zhun
  • Lju Chao
  • Van Zhun-Duan'
  • Juan' Khun-Chzhun
  • Go Vehn'-Min'
  • Jan' Suj-Chao
  • Baj Min'
RU2285696C2
MITOCHONDRIA-TARGETED UBIQUINONE DERIVATIVES AS OXIDATIVE STRESS REDUCING ANTIOXIDANTS, PHARMACEUTICAL COMPOSITION, METHOD OF PRODUCTION AND METHOD OF TREATMENT 2004
  • Tehjlor Kennet Martin
  • Smit Robin
RU2487880C2

RU 2 389 491 C2

Authors

Frehss Bernar

Loshar Juber

Dates

2010-05-20Published

2005-10-19Filed